首页> 外国专利> 2-Oxo pyrrolidino)-acetic hydrazides - nootropic agents used to treat cerebral sclerosis, memory lapses and as inter for piracetame

2-Oxo pyrrolidino)-acetic hydrazides - nootropic agents used to treat cerebral sclerosis, memory lapses and as inter for piracetame

机译:2-Oxo pyrrolidino)-乙酰肼-促智药,用于治疗脑硬化,记忆力减退以及吡拉西坦的中间体

摘要

acid hydrazides of formula (I) (where R1=H or (II) are used in the prepn. of 2-oxo-pyrrolidino acetamide of formula (Ia) by reduction pref. by hydrogenation under press. in the presence of a catalyst. (I) are psychotherapeutics used as nootropic agents and have superior activity to (Ia). (Ia) (piracetame) is used against kinetosis (e.g. seasickness), for treatment of senile involution as a nootropic agent having favourable influence on the learning aptitude. (I) is used to treat cerebral sclerosis and memmory losses due to circulatory troubles caused by alcoholism or traumatism. They are generally administered orally in daily doses of 1.2-2.4g pref. as unit doses of 100-500 mg (esp. 200-400mg).
机译:式(I)的酰肼(其中R 1 = H或(II))通过在压力下在催化剂的存在下通过氢化的还原进行还原而用于式(Ia)的2-氧代-吡咯烷基氨基乙酰胺的制备中。 (I)是用作促智药的心理治疗药,具有比(Ia)更好的活性。(Ia)(吡乙酰胺)可以用于预防运动性疾病(例如晕船),作为对学习能力有有利影响的促智药,用于治疗衰老。 (I)用于治疗因酒精中毒或外伤引起的循环系统问题而导致的脑硬化和记忆丧失,通常口服,每日剂量为1.2-2.4克(每天),单位剂量为100-500毫克(尤其是200-500毫克) 400mg)。

著录项

  • 公开/公告号FR2361882A1

    专利类型

  • 公开/公告日1978-03-17

    原文格式PDF

  • 申请/专利权人 CHEMISCHES LABORATORIUM F W LANG;

    申请/专利号FR19760003735

  • 发明设计人

    申请日1976-02-11

  • 分类号A61K31/40;C07D207/26;

  • 国家 FR

  • 入库时间 2022-08-22 21:45:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号